Excess mortality, length of stay and cost attributable to candidaemia

Journal of Infection

Volumn 59, Issue 5, 2009, Pages 360-365

  Hassan, I ^a   Powell, G ^b   Sidhu, M ^c   Hart, W M ^d   Denning, D W ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ASTELLAS PHARMA EUROPE LTD   (United Kingdom)

^d EcoStat Consulting UK   (United Kingdom)

Author keywords

Candida; ICU; Mortality

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDEMIA; CASE CONTROL STUDY; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DISEASE SEVERITY; FEMALE; HOSPITAL COST; HUMAN; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MORTALITY; RETROSPECTIVE STUDY; UNITED KINGDOM; WARD; CANDIDA ALBICANS; CANDIDIASIS; ECONOMICS; FUNGEMIA; ISOLATION AND PURIFICATION; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; STATISTICS;

ADOLESCENT; ADULT; AGED; CANDIDA ALBICANS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; FEMALE; FUNGEMIA; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70449732623     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.08.020     Document Type: Article

References (20)

1. Bille J., Marchetti O., and Calandra T. Changing face of health-care associated fungal infections. Curr Opin Infect Dis 18 (2005) 314-319
2. Morris M., and Villmann M. Echinocandins in the management of invasive fungal infections, part 1. Am J Health-Syst Pharm 63 (2006) 1693-1703
3. Partnership N.I.N.S.S. Surveillance of hospital-acquired bacteraemia in English hospitals 1997-2002 (2002), Health Protection Agency, London
4. Kibbler C.C., Seaton S., Barnes R.A., Gransden W.R., Holliman R.E., Johnson E.M., et al. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 54 (2003) 18-24
5. Odds F., Hanson M., Davidson A., Jacobsen M., Wright P., Whyte J., et al. One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol 56 (2007) 1066-1075
6. HPA. Candidaemia in England, Wales and Northern Ireland: 2007 - overall trend in reports (www.hpa.org.uk) (accessed on 28/02/2009).
7. Falagas M.E., Apostolou K.E., and Pappas V.D. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis 25 (2006) 419-425
8. Spellberg B., Filler S., and Edwards J. Current treatment strategies for disseminated candidiasis. Clin Infect Dis 42 (2006) 244-251
9. Morgan J., Meltzer M.J., Plikaytis B.D., Sofair A.N., Huie-White S., Wilcox S., et al. Excess mortality, hospital stay, and cost due to candidaemia: a case-control study using data from population-based candidaemia surveillance. Infect Control Hosp Epidemiol 26 (2005) 540-547
10. Wey S.B., Mori M., Pfaller M.A., Woolson R.F., and Wenzel R.P. Hospital-acquired candidaemia: the attributable mortality and excess length of stay. Arch Intern Med 148 (1988) 2642-2645
11. Zaoutis T.E., Argon J., Chu J., Berlin J.A., Walsh T.J., and Feudtner C. The epidemiology and attributable outcomes of candidaemia in adults and children hospitalized in the United States: A propensity analysis. Clin Infect Dis 41 (2005) 1232-1239
12. Wenzel R.P. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 20 (1995) 1531-1534
13. Rex J.H., Pappas P.G., Karchmer A.W., Sobel J., Edwards J.E., Hadley S., et al. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis 36 (2003) 1221-1228
14. Negrini D., Sheppard L., Mills G.H., Jacobs P., Rapoport J., Bourne R.S., et al. International programme for resource use in critical care (IPOC) a methodology and initial results of cost and provision in four European countries. Acta Anaesthesiol Scand 50 (2006) 72-79
15. Adult Intensive Care Services in Northern Ireland. House of Commons Hansard Written Answers for 10 Oct 2005.
16. North Cumbria Acute Hospitals NHS Trust. Private Patient Tariff 2007/2008 as from 01.04.07.
17. Gaudlaugsson O., Gillespie S., Lee K., Berg J.V., Hu J., Messer S., et al. Attributable mortality of nosocomial candidaemia, revisited. Clin Infect Dis 41 (2005) 1232-1239
18. Blot S.I., Vandewooude K.H., Hoste E.A., and Colardyn F.A. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 113 (2002) 480-485
19. Nieto-Rodriguez J.A., Kusne S., Mañez R., Irish W., Linden P., Magnone M., et al. Factors associated with the development of candidaemia and candidaemia-related death among liver transplant patients. Ann Surg 223 (1996) 70-76
20. Leroy O., Gangneux J.P., Montravers P., Mira J.P., Gouin F., Sollet J.P., et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 37 (2009) 1612-1618